Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia reperfusion injury in isolated perfused rat hearts

被引:24
作者
Illing, B [1 ]
Horn, M [1 ]
Han, H [1 ]
Hahn, S [1 ]
Bureik, P [1 ]
Ertl, G [1 ]
Neubauer, S [1 ]
机构
[1] UNIV WURZBURG,MED KLIN,D-97080 WURZBURG,GERMANY
关键词
ET(A)-receptor antagonist BQ610; ischemia/reperfusion injury; mechanical function; high-energy phosphate metabolism;
D O I
10.1097/00005344-199604000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endothelin-1 (ET-1) has been suggested to be involved in the pathophysiology of ischemia/reperfusion injury, but direct proof for this is still sparse. We tested whether protection of high-energy phosphate metabolism contributes to the beneficial effects of ET(A) receptor antagonists during ischemia/reperfusion. In isolated, buffer-perfused rat hearts, isovolumic function was measured by a left ventricular (LV) balloon, and P-31 nuclear magnetic resonance spectra were continuously recorded. Two protocols were performed: (a) 15-min control, 30-min total, global ischemia, and 15-min reperfusion; and (b) 15-min control, 15-min total, global ischemia, and 30-min reperfusion. Treatment with BQ610 (1.75 mu g/min) or saline was started during control and continued throughout the protocol. BQ610 did not affect function or energy metabolism under control conditions. In BQ610-treated hearts subjected to 30-min ischemia, time to ischemic contracture was significantly delayed (treated 10.6 +/- 0.4 min; untreated 8.1 +/- 0.7 min), and end-diastolic pressure (EDP) remained lower (after 30-min ischemia 26 +/- 2 vs. 35 +/- 2 mm Hg). In addition, recovery of mechanical function in BQ610-treated hearts was accelerated during reperfusion. BQ610 did not affect ATP but significantly accelerated and increased creatine phosphate (51 +/- 7 vs. 37 +/- 3%) recovery on reperfusion after 30-min ischemia. BQ610-treated hearts subjected to 15-min ischemia also showed lower EDP during ischemia and accelerated recovery of mechanical function during reperfusion. However, in this case, there were no differences in high-energy phosphate concentrations between treated and untreated hearts. We conclude that the protective action of BQ610 on mechanical function during ischemia/reperfusion injury can be but is not consistently associated with beneficial effects on cardiac high-energy phosphate metabolism.
引用
收藏
页码:487 / 494
页数:8
相关论文
共 28 条
[1]   NA-H EXCHANGE IN MYOCARDIUM - EFFECTS OF HYPOXIA AND ACIDIFICATION ON NA AND CA [J].
ANDERSON, SE ;
MURPHY, E ;
STEENBERGEN, C ;
LONDON, RE ;
CALA, PM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (06) :C940-C948
[2]  
ARI H, 1990, NATURE, V348, P730
[4]  
BAZIL MK, 1992, J CARDIOVASC PHARM, V20, P940, DOI 10.1097/00005344-199212000-00014
[5]   ENDOTHELIN RELEASE DURING ISCHEMIA AND REPERFUSION OF ISOLATED PERFUSED RAT HEARTS [J].
BRUNNER, F ;
DUTOIT, EF ;
OPIE, LH .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 (11) :1291-1305
[6]   DUAL CARDIOVASCULAR EFFECTS OF ENDOTHELIN-1 DISSOCIATED BY BQ-153, A NOVEL ET(A) RECEPTOR ANTAGONIST [J].
CIRINO, M ;
BATTISTINI, B ;
YANO, M ;
RODGER, IW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (04) :587-594
[7]   ROLE OF ENDOTHELIN DURING REPERFUSION AFTER ISCHEMIA IN ISOLATED-PERFUSED RAT-HEART [J].
DAGASSAN, PH ;
BREU, V ;
CLOZEL, M ;
CLOZEL, JP .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 24 (06) :867-874
[8]   EFFECTS OF ENDOTHELIN-1 AT PATHOPHYSIOLOGIC CONCENTRATIONS ON CORONARY PERFUSION AND MECHANICAL FUNCTION OF NORMAL AND POSTISCHEMIC MYOCARDIUM [J].
DONCKIER, J ;
HANET, C ;
STOLERU, L ;
VANMECHELEN, H ;
GALANTI, L ;
HAYASHIDA, W ;
KEYEUX, A ;
KETELSLEGERS, JM ;
POULEUR, H .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1994, 23 (02) :212-219
[9]  
GROVER GJ, 1992, J PHARMACOL EXP THER, V263, P1074
[10]   THE ENDOTHELIN-1 RECEPTOR ANTAGONIST BQ-123 REDUCES INFARCT SIZE IN A CANINE MODEL OF CORONARY-OCCLUSION AND REPERFUSION [J].
GROVER, GJ ;
DZWONCZYK, S ;
PARHAM, CS .
CARDIOVASCULAR RESEARCH, 1993, 27 (09) :1613-1618